- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00129701
Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation
Proposal to Study Whether we Can Reduce Hospital Attendance by Those With Respiratory Conditions Without Compromising Care by the Use of Telephone Consultation
Study Overview
Status
Intervention / Treatment
Detailed Description
Patients to be included in the study would be those attending 3 respiratory clinics. The patients would be asked if they were willing to have a telephone consultation instead of their next face to face consultation and this would be explained to them.
"Many patients attending a Chest Clinic need to do so only once. For others their condition merits regular review. Most of these people need to come to the clinic because they need chest x-rays, blood tests or breathing tests. However some patients return for review of their condition without needing any specialist investigations. We are keen to assess what proportion of our patients would be suitable for telephone consultations rather than face to face consultations and to see what advantages there might be for both patients and doctors. We are therefore interested to assess the use of telephone consultation where suitable and would like to know if you would be willing to try telephone consultation for your next appointment. In the case of telephone consultation you would be offered a day, date and time at which you would be phoned. Your consultant, would then ring you him or herself within half an hour of the appointed time {and procedurally it has been agreed by the trial participants that if, for any reason, during the trial period they are delayed with the previous patient they will excuse themselves to telephone the following patient to say that they have been delayed and they will ring them back within 15 minutes, for example} and with your clinical notes in front of them he or she would enquire in the usual way regarding how you feel, ask about your symptoms and give advice regarding any concerns you may have or advise regarding changes in treatment. You would subsequently receive a copy of the letter summarising the telephone consultation when it was sent to your general practitioner. If the telephone consultation suggested that you needed to be seen in the clinic you would be offered an appointment within two weeks of the telephone call."
Demographic details and disease diagnosis would be recorded, for those not deemed suitable or for those not wishing to take part and they would continue to attend traditional face to face consultations. Those having a telephone consultation would subsequently revert to traditional consultation pending results of the trial. Frequency of planned consultation would be as per the consultant's usual practice.
Procedurally, it was agreed that for those patients agreeing to have their next consultation by telephone, the doctor would check the phone number which they wished for the investigators to use and this would be inserted in the notes at the end of the previous consultation with a large black box around it, so that it could easily be spotted at the time of the telephone consultation.
For all patients the following observations would be made: length of the telephone consultation, fail to be available when telephoned rate, and length of each face to face consultation.
For each face to face consultation the following information would be recorded: the time they left home; time of arrival at hospital, time spent waiting for consultation, expense of attendance, both travel costs but also any indirect costs such as babysitting charges and loss of earnings. For each telephone consultation the number of patients having to be reviewed within the next 2 weeks of the telephone consultation would be recorded, whether such expedited follow up was at the patient's or the doctor's behest.
After both the telephone consultation and their subsequent face to face consultation the patients would be asked to complete the post consultation patient satisfaction questionnaire, the MISS 21 questionnaire and the Howie Enablement Instrument. Patients would be posted these scales by first class post on the day of a telephone consultation and handed them for completion after a face to face consultation and on each occasion they would be given a stamped addressed envelope in which to return the completed scores.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, W6 8RF
- NHLI Imperial College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients who had already attended a respiratory clinic on at least two occasions and in whom it was perceived that there was a need for continued follow up in a hospital clinic with review needed more often than once per year Patients with no need for physical examinations or investigations such as chest X-rays, blood tests or lung function tests at every attendance Patients who had access to a confidential telephone line Patients who had no mental, hearing or linguistic problems
Exclusion criteria
New patients or those who need frequent follow up Patients with mental or cognitive issues Patients requiring physical examination and testing.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients attending
Patients recruited to have a telephone consultation and then at the next appointment a face-to-face appointment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction
Time Frame: After consultation within 1 months
|
MISS-21 satisfaction scale, The 21 items are scored using a 7-point Likert scale with responses ranging from 1 ("Very strongly disagree") to 7 ("Very strongly agree").
Maximum is 147 Very strong satisfaction - best outcome, minimum 21 very strong dissatisfaction.
|
After consultation within 1 months
|
|
Patients Needing Expedited Follow up
Time Frame: After phone consultation within 2 weeks
|
Number of participants who were telephoned and needed expedited follow-up
|
After phone consultation within 2 weeks
|
|
Costs Associated With Traditional Face to Face Consultation
Time Frame: 1 year
|
Patient costs attending hospital appointments compare to phone consultations
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Martyn R Partridge, MD FRCP, NHLI Imperial College
Publications and helpful links
General Publications
- Car J, Sheikh A. Telephone consultations. BMJ. 2003 May 3;326(7396):966-9. doi: 10.1136/bmj.326.7396.966. No abstract available.
- Greineder DK, Loane KC, Parks P. Reduction in resource utilization by an asthma outreach program. Arch Pediatr Adolesc Med. 1995 Apr;149(4):415-20. doi: 10.1001/archpedi.1995.02170160069010.
- Partridge MR. An assessment of the feasibility of telephone and email consultation in a chest clinic. Patient Educ Couns. 2004 Jul;54(1):11-3. doi: 10.1016/S0738-3991(03)00166-6.
- Pal B. Following up outpatients by telephone: pilot study. BMJ. 1998 May 30;316(7145):1647. doi: 10.1136/bmj.316.7145.1647. No abstract available.
- Pinnock H, Bawden R, Proctor S, Wolfe S, Scullion J, Price D, Sheikh A. Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial. BMJ. 2003 Mar 1;326(7387):477-9. doi: 10.1136/bmj.326.7387.477.
- Roberts NJ, Partridge MR. Telephone consultations in secondary care. Respir Med. 2007 Aug;101(8):1665-9. doi: 10.1016/j.rmed.2007.03.003. Epub 2007 Apr 19.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NHLICX3510
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.